178 related articles for article (PubMed ID: 11742326)
1. Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years.
Lundgren E; Lind L; Palmér M; Jakobsson S; Ljunghall S; Rastad J
Surgery; 2001 Dec; 130(6):978-85. PubMed ID: 11742326
[TBL] [Abstract][Full Text] [Related]
2. Conjoint effects of serum calcium and phosphate on risk of total, cardiovascular, and noncardiovascular mortality in the community.
Larsson TE; Olauson H; Hagström E; Ingelsson E; Arnlöv J; Lind L; Sundström J
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):333-9. PubMed ID: 19948843
[TBL] [Abstract][Full Text] [Related]
3. Causes of death in patients previously operated on for primary hyperparathyroidism.
Ronni-Sivula H
Ann Chir Gynaecol; 1985; 74(1):13-8. PubMed ID: 4015016
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal studies of mild primary hyperparathyroidism.
Ljunghall S; Jakobsson S; Joborn C; Palmér M; Rastad J; Akerström G
J Bone Miner Res; 1991 Oct; 6 Suppl 2():S111-6; discussion S121-4. PubMed ID: 1763661
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago.
Lundgren E; Hagström EG; Lundin J; Winnerbäck K; Roos J; Ljunghall S; Rastad J
World J Surg; 2002 Aug; 26(8):931-6. PubMed ID: 12045863
[TBL] [Abstract][Full Text] [Related]
6. Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease.
Pasqualini L; Schillaci G; Pirro M; Vaudo G; Siepi D; Innocente S; Ciuffetti G; Mannarino E
J Intern Med; 2007 Dec; 262(6):668-77. PubMed ID: 17908164
[TBL] [Abstract][Full Text] [Related]
7. Serum phosphorus and cardiovascular mortality in type 2 diabetes.
Chonchol M; Dale R; Schrier RW; Estacio R
Am J Med; 2009 Apr; 122(4):380-6. PubMed ID: 19332233
[TBL] [Abstract][Full Text] [Related]
8. Serum calcium in thyroid disease.
Begic-Karup S; Wagner B; Raber W; Schneider B; Hamwi A; Waldhäusl W; Vierhapper H
Wien Klin Wochenschr; 2001 Jan; 113(1-2):65-8. PubMed ID: 11233472
[TBL] [Abstract][Full Text] [Related]
9. Intima-media thickness measurement of the carotid artery in patients with primary hyperparathyroidism. A prospective case-control study and long-term follow-up.
Lumachi F; Ermani M; Frego M; Pilon F; Filosa T; Di Cristofaro L; De Lotto F; Fallo F
In Vivo; 2006; 20(6B):887-90. PubMed ID: 17203784
[TBL] [Abstract][Full Text] [Related]
10. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
Menon V; Greene T; Pereira AA; Wang X; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism.
Carty SE; Roberts MM; Virji MA; Haywood L; Yim JH
Surgery; 2002 Dec; 132(6):1086-92; discussion 1092-3. PubMed ID: 12490859
[TBL] [Abstract][Full Text] [Related]
13. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism.
Bergenfelz A; Lindblom P; Lindergård B; Valdemarsson S; Westerdahl J
World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497
[TBL] [Abstract][Full Text] [Related]
14. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism.
Costa-Hong V; Jorgetti V; Gowdak LH; Moyses RM; Krieger EM; De Lima JJ
Surgery; 2007 Nov; 142(5):699-703. PubMed ID: 17981190
[TBL] [Abstract][Full Text] [Related]
15. Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline.
Noordzij M; Korevaar JC; Dekker FW; Boeschoten EW; Bos WJ; Krediet RT; Bossuyt PM; Geskus RB;
Blood Purif; 2008; 26(3):231-7. PubMed ID: 18305386
[TBL] [Abstract][Full Text] [Related]
16. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
17. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
[TBL] [Abstract][Full Text] [Related]
18. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study.
Lee AJ; Wang JJ; Kifley A; Mitchell P
Ophthalmology; 2006 Jul; 113(7):1069-76. PubMed ID: 16815396
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia due to primary hyperparathyroidism or malignant disease. Evaluated by means of biochemical tests and the steroid suppression test.
Kvetny J; Orthman-Brask H; Frederiksen PK; Jest P; Jensen E; Jacobsen JG
Acta Med Scand; 1982; 212(3):163-6. PubMed ID: 7148507
[TBL] [Abstract][Full Text] [Related]
20. Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism.
Brunaud L; Germain A; Zarnegar R; Rancier M; Alrasheedi S; Caillard C; Ayav A; Weryha G; Mirallie E; Bresler L
Surgery; 2009 Dec; 146(6):1035-41. PubMed ID: 19958930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
